Is the incidence and prevalence of inhibitors greater with recombinant products? Yes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is the incidence and prevalence of inhibitors greater with recombinant products? Yes

Published:2004-06 Issue:6 Volume:2 Page:861-862
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Aledort L. M.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2004.00731.x/fullpdf

Reference11 articles.

1. Inhibitors in hemophilia patients: Current status and management

2. Haemophiliacs with factor VIII inhibitors in Finland: prevalence, incidence and outcome

3. Incidence of inhibitors in patients with severe and moderate hemophilia a treated with factor VIII concentrates

4. Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma‐derived FVIII/VWF complex shows higher protection against inhibitors than isolated FVIII after infusion in haemophilic patients: A translational study;Haemophilia;2022-06-02

2. Immune Responses to Plasma-Derived Versus Recombinant FVIII Products;Frontiers in Immunology;2021-01-22

3. Evolution of clotting factor concentrates prescriptions and impact of recommendations of prophylaxis in children with haemophilia;Therapies;2021-01

4. Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States;Journal of Medical Economics;2018-06-06

5. Product type and other environmental risk factors for inhibitor development in severe hemophilia A;Research and Practice in Thrombosis and Haemostasis;2018-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3